Washington Senate Bill 5594: Revised for engrossed: Concerning biosimilar medicines and interchangeable biological products.

Washington · 2025-2026 Regular Session

What it does

Revised for engrossed: Concerning biosimilar medicines and interchangeable biological products.

Latest action

By resolution, returned to Senate Rules Committee for third reading. (2026-03-12)

See how SB 5594 affects you on CapitolKey

Browse more bills · CapitolKey home